Test Price
2,800 AED✅ Home Collection Available
FGFR2 Gene Sequencing for Craniosynostosis & Dysmorphology (NGS) in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FGFR2 لمتلازمات تعظم الدروز وخلل التنسج في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summaryملخص تنفيذي: فحص شامل لجين FGFR2 بتقنية التسلسل المتقدم، دقة تشخيصية فائقة، وخدمات سحب منزلية معتمدة.
- ✓Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS processing. (ضمان الدقة: حساسية تشخيصية %99.9 عبر معالجة معتمدة من الأيزو)
- ✓Premium Logistics: Paid hospital-grade cold-chain home collection & VIP mobile phlebotomy (8 AM – 11 PM). (خدمات لوجستية متميزة: سحب منزلي معزول بالتبريد على مدار الساعة)
- ✓Clinical Guidance: Complimentary telephonic post-test interpretation with a DHA-licensed genetic counselor. (إرشادات سريرية: استشارة هاتفية بعد الفحص لتفسير النتائج)
- ✓Insurance: Direct billing verification via WhatsApp +971 54 548 8731. (تأكيد التأمين المباشر عبر واتساب)
Test Overview: FGFR2 Gene NGS Analysis
This next-generation sequencing test analyzes the entire coding region of the FGFR2 gene to detect pathogenic variants associated with craniosynostosis syndromes (scaphocephaly, Crouzon, Apert, Pfeiffer), maxillary retrusion, and intellectual disability. يبحث هذا الفحص في كامل جين FGFR2 لتحديد الطفرات المسببة لمتلازمات تعظم الدروز وتراجع الفك العلوي والإعاقة الذهنية.
| Feature | Our Test (NGS) | Standard Single-Gene Sanger |
|---|---|---|
| Precision | 99.9% analytical sensitivity; all exons + splice sites | ~99% but limited to known hotspots |
| Method | Illumina NGS with confirmatory Sanger | Sanger sequencing of selected exons |
| Speed | 3–4 weeks (complete gene coverage) | 6–8 weeks (sequential testing) |
| Clinical Actionability | Full variant interpretation per ACMG guidelines | Limited to known mutations |
Physician Insight & Safety Protocol
“This test is a vital tool for diagnosing FGFR2-related craniosynostosis syndromes, but it must be interpreted alongside clinical findings and genetic counseling. I advise discussing results with a pediatric geneticist. Never stop prescribed medications without your doctor's approval.”
— Dr. Prabhakar Reddy, DHA License 61713011
Medication Warning:
Do not discontinue or adjust any prescribed medication without direct consultation with your treating physician. This genetic test does not replace ongoing clinical management.
Safety & Exclusion Criteria
- Not intended for asymptomatic minors without clinical indication or genetic counseling per UAE CDS Law 2026.
- Exclusion: Patients on high-dose anticoagulants (blood draw contraindication) unless cleared by a physician.
- Emergency Red Flags: Seek immediate medical attention if experiencing increased intracranial pressure symptoms (severe headaches, vomiting, vision changes) regardless of test status.
- Home collection phlebotomists are trained to manage minor adverse events; 24/7 hotline available.
Patient FAQ & Clinical Guidance
1. What does this FGFR2 NGS test detect, and who should consider it?
This test sequences the entire FGFR2 gene to identify pathogenic variants causing craniosynostosis, midface hypoplasia, and intellectual disability, making it essential for early diagnosis in infants with skull abnormalities. Clinicians, including pediatricians and clinical geneticists, may recommend it for syndromic craniosynostosis, familial history, or dysmorphic features. Genetic counseling is mandatory.
يبحث هذا التحليل عن طفرات جينية في FGFR2 تؤدي إلى تعظم الدروز ونقص التنسج الفكي، ويُوصى به للأطفال ذوي تشوهات الجمجمة أو التاريخ العائلي.
2. How is the sample collected, and what is the TAT?
A certified phlebotomist performs a simple venous blood draw at your home using a cold-chain kit, or you may submit a dried blood spot on an FTA card, with results delivered in 3-4 weeks. The lab accepts whole blood (EDTA tube), extracted DNA, or FTA card. Home collection is available daily 8 AM–11 PM. The test takes 21–28 working days due to complex bioinformatics analysis.
يمكن جمع العينة في المنزل عبر سحب دم وريدي أو بقعة دم على بطاقة FTA، وتظهر النتائج خلال 3-4 أسابيع.
3. Is this test covered by insurance in the UAE?
Many UAE insurers cover FGFR2 NGS testing when medically necessary; our team verifies your coverage before the and manages direct billing to streamline your experience. We require a valid referral from a DHA-licensed physician. For pre-authorization, send your insurance card and referral via WhatsApp to +971 54 548 8731. Self-pay options are also available at 2800 AED.
تغطي العديد من شركات التأمين في الإمارات هذا الفحص بشرط وجود إحالة طبية، ويتم التحقق من التغطية قبل سحب العينة.
UAE Legal Compliance: This service adheres to Federal Decree-Law No. 41 of 2024 (Article 87), the CDS Law 2026 for minors, and the UAE Personal Data Protection Law. All genetic data is anonymized and stored on encrypted servers within the UAE. Laboratory license: 9834453. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
جميع الإجراءات متوافقة مع القوانين الاتحادية لدولة الإمارات، وبياناتك الجينية محمية بموجب قانون حماية البيانات الشخصية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians